EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Stellate Ganglion Block Relieves Long COVID-19 Symptoms in 86% of Patients: A Retrospective Cohort Study

Lisa Pearson, Alfred Maina, Taylor Compratt, Sherri Harden, Abbey Aaroe, Whitney Copas, Leah Thompson

Cureus · 13.09.2023

DOI: 10.7759/cureus.45161 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cureus, erschienen am 13.09.2023. Verfasst von Lisa Pearson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pain Management, University of South Florida, Tampa, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-COVID-19 condition, also known as long COVID-19 syndrome and post-acute sequelae of SARS-CoV-2, encompasses an array of symptoms that persist well beyond the initial phase of the viral infection. These symptoms can range in intensity, from mild and manageable to severe and incapacitating. Due to the evolving nature of the SARS-CoV-2 pandemic, treatment protocols for the illness are in a constant state of evolution. The early stage of long COVID-19 syndrome contributes to a dearth of treatment protocols based on empirical evidence, while the absence of a conclusive pathophysiological understanding further complicates the development of such protocols. Current treatment regimens include homeopathic medicine, specialist system-focused treatments, infusion therapies, hyperbaric oxygenation, antivirals, and polypharmacy. The physiological, psychological, and societal impact of long COVID-19 cannot be approached casually and must govern the intensity with which the healthcare community approaches the treatment of long COVID-19 syndrome. In this 41-patient cohort study from a chronic pain management practice, the use of either unilateral or bilateral stellate ganglion block (SGB) was explored to manage symptoms associated with long COVID-19 syndrome. Results indicated that a substantial proportion of patients (86%) experienced a reduction of their symptoms following SGB treatment.

Schlagwörter

Stichwörter der Autor:innen

autonomic nervous system modulationlong covid syndromelong covid-19post-covid autonomic dysfunctionstellate ganglion blockstellate ganglion block (sgb)treatment for long covid

Autor:innen und Institutionen

  • Pain Management, University of South Florida, Tampa, USA.
  • Pain Management, Metamorphosis Ltd., Canon City, USA.
  • Pain Management, Texas Christian University, Fort Worth, USA.
  • Anesthesia, Missouri State University, Springfield, USA.
  • Pain Management, Metamorphosis Ltd., Colorado Springs, USA.
  • Nursing, University of Colorado, Denver, USA.

Zitieren

APA

Pearson, L., Maina, A., Compratt, T., Harden, S., Aaroe, A., Copas, W., & Thompson, L. (2023). Stellate Ganglion Block Relieves Long COVID-19 Symptoms in 86% of Patients: A Retrospective Cohort Study. Cureus. https://doi.org/10.7759/cureus.45161

Vancouver

Pearson L, Maina A, Compratt T, Harden S, Aaroe A, Copas W, et al. Stellate Ganglion Block Relieves Long COVID-19 Symptoms in 86% of Patients: A Retrospective Cohort Study. Cureus. 2023. doi:10.7759/cureus.45161

BibTeX
@article{Pearson2023,
  author = {Pearson, Lisa and Maina, Alfred and Compratt, Taylor and Harden, Sherri and Aaroe, Abbey and Copas, Whitney and Thompson, Leah},
  title = {Stellate Ganglion Block Relieves Long COVID-19 Symptoms in 86% of Patients: A Retrospective Cohort Study},
  journal = {Cureus},
  year = {2023},
  doi = {10.7759/cureus.45161}
}
Kostenlos starten →